These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 9806028)
1. Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection. Pontesilli O; Klein MR; Kerkhof-Garde SR; Pakker NG; de Wolf F; Schuitemaker H; Miedema F J Infect Dis; 1998 Oct; 178(4):1008-18. PubMed ID: 9806028 [TBL] [Abstract][Full Text] [Related]
2. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. Klein MR; van Baalen CA; Holwerda AM; Kerkhof Garde SR; Bende RJ; Keet IP; Eeftinck-Schattenkerk JK; Osterhaus AD; Schuitemaker H; Miedema F J Exp Med; 1995 Apr; 181(4):1365-72. PubMed ID: 7699324 [TBL] [Abstract][Full Text] [Related]
3. Kinetics of immune functions and virus replication during HIV-1 infection. Pontesilli O; Klein MR; Kerkhof-Garde SR; Pakker NG; de Wolf F; Schuitemaker H; Miedema F Immunol Lett; 1997 Jun; 57(1-3):125-30. PubMed ID: 9232438 [TBL] [Abstract][Full Text] [Related]
4. High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection. McFarland EJ; Harding PA; Luckey D; Conway B; Young RK; Kuritzkes DR J Infect Dis; 1994 Oct; 170(4):766-74. PubMed ID: 7930716 [TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus type 1 (HIV-1)--and Epstein-Barr virus--specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1--infected persons. Geretti AM; Dings ME; van Els CA; van Baalen CA; Wijnholds FJ; Borleffs JC; Osterhaus AD J Infect Dis; 1996 Jul; 174(1):34-45. PubMed ID: 8656011 [TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. Carmichael A; Jin X; Sissons P; Borysiewicz L J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890 [TBL] [Abstract][Full Text] [Related]
7. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef. Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824 [TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors. Betts MR; Krowka JF; Kepler TB; Davidian M; Christopherson C; Kwok S; Louie L; Eron J; Sheppard H; Frelinger JA AIDS Res Hum Retroviruses; 1999 Sep; 15(13):1219-28. PubMed ID: 10480635 [TBL] [Abstract][Full Text] [Related]
9. Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients. Durali D; Morvan J; Letourneur F; Schmitt D; Guegan N; Dalod M; Saragosti S; Sicard D; Levy JP; Gomard E J Virol; 1998 May; 72(5):3547-53. PubMed ID: 9557634 [TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS. van Baalen CA; Pontesilli O; Huisman RC; Geretti AM; Klein MR; de Wolf F; Miedema F; Gruters RA; Osterhaus AD J Gen Virol; 1997 Aug; 78 ( Pt 8)():1913-8. PubMed ID: 9266987 [TBL] [Abstract][Full Text] [Related]
11. Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients. Legrand E; Pellegrin I; Neau D; Pellegrin JL; Ragnaud JM; Dupon M; Guillemain B; Fleury HJ AIDS Res Hum Retroviruses; 1997 Nov; 13(16):1383-94. PubMed ID: 9359658 [TBL] [Abstract][Full Text] [Related]
12. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses. Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728 [TBL] [Abstract][Full Text] [Related]
13. An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. Jin X; Ogg G; Bonhoeffer S; Safrit J; Vesanen M; Bauer D; Chen D; Cao Y; Demoitie MA; Zhang L; Markowitz M; Nixon D; McMichael A; Ho DD Mol Med; 2000 Sep; 6(9):803-9. PubMed ID: 11071274 [TBL] [Abstract][Full Text] [Related]
14. HIV-1 env, nef, and gag-specific T-cell immunity in mice: conserved epitopes in nef p27 and gag p25 proteins. Michel F; Hoffenbach A; Froussard P; Langlade-Demoyen P; Kaczorek M; Kieny MP; Plata F AIDS Res Hum Retroviruses; 1992 Apr; 8(4):469-78. PubMed ID: 1376136 [TBL] [Abstract][Full Text] [Related]
15. Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men. Rinaldo CR; Beltz LA; Huang XL; Gupta P; Fan Z; Torpey DJ AIDS Res Hum Retroviruses; 1995 Apr; 11(4):481-9. PubMed ID: 7632463 [TBL] [Abstract][Full Text] [Related]
16. Characterization of a polyclonal cytolytic T lymphocyte response to human immunodeficiency virus in persons without clinical progression. Lubaki NM; Ray SC; Dhruva B; Quinn TC; Siliciano RF; Bollinger RC J Infect Dis; 1997 Jun; 175(6):1360-7. PubMed ID: 9180175 [TBL] [Abstract][Full Text] [Related]
17. Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice. Chenciner N; Michel F; Dadaglio G; Langlade-Demoyen P; Hoffenbach A; Leroux A; Garcia-Pons F; Rautmann G; Guy B; Guillon JM Eur J Immunol; 1989 Sep; 19(9):1537-44. PubMed ID: 2676560 [TBL] [Abstract][Full Text] [Related]
18. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants. Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426 [TBL] [Abstract][Full Text] [Related]
19. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection. Wilson SE; Pedersen SL; Kunich JC; Wilkins VL; Mann DL; Mazzara GP; Tartaglia J; Celum CL; Sheppard HW AIDS Res Hum Retroviruses; 1998 Jul; 14(11):925-37. PubMed ID: 9686639 [TBL] [Abstract][Full Text] [Related]
20. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis. Hadida F; Parrot A; Kieny MP; Sadat-Sowti B; Mayaud C; Debre P; Autran B J Clin Invest; 1992 Jan; 89(1):53-60. PubMed ID: 1370302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]